GENELUX Corp — Director's Dealing 2025

Aug 29, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENELUX Corp (GNLX)
CIK: 0001231457
Period of Report: 2025-08-27

Reporting Person: Yu Yong (SVP, Clinical Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-27	Common Stock	A	101480	—	Acquired	150036	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-27	Stock Option (Right to Buy)	$3.64	A	134520	Acquired	2035-08-26	Common stock (134520)	Direct

Footnotes

F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter.

F2: Includes 916 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan.

F3: The shares subject to the option will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter.